Latest Regulation News

Page 8 of 166
Alterity Therapeutics says it has begun operational preparations for a Phase 3 ATH434 trial after FDA minutes confirmed the proposed design and registrational pathway in Multiple System Atrophy. The company ended September with A$41.3 million in cash, while a new US patent extends protection for ATH434 to 2045.
Ada Torres
Ada Torres
30 Oct 2026
Sequoia Financial Group reported a sharp first-quarter revenue decline and pretax loss as authorised representatives left its InterPrac licence. Cash rose to A$11.4 million, but the balance was bolstered by the sale of Centrepoint Alliance shares while ASIC continues to question documentation linked to the InterPrac exit.
Claire Turing
Claire Turing
30 Oct 2026
Epsilon Healthcare delivered record September-quarter customer receipts of A$3.9 million, while nine-month revenue reached A$11.5 million. The growth story is strengthening, but cash fell to A$997,000 and quarterly operating cash flow remained negative.
Ada Torres
Ada Torres
30 Oct 2026
KALiNA Power says its Alberta gas-fired generation portfolio is moving closer to commercial contracting as data centre demand, regulatory reform and grid access rules converge. The company ended the September quarter with A$11.4 million in cash, no debt and an estimated 13 quarters of funding at its current operating burn.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Caravel Minerals has completed the mining component of its Caravel Copper Project feasibility study, but the full DFS has slipped into the fourth quarter of 2026. The company is also reviewing process plant costs while holding $16.8 million in cash and reporting an estimated 4.6 quarters of funding at the quarter’s outflow rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cann Group’s September quarter delivered a sharp increase in revenue and exports as its Mildura GMP facility gained traction in Europe. But with just $49,000 in cash, $626,000 of undrawn debt capacity and an estimated 0.9 quarters of funding, the recovery still depends on collections and further financing.
Ada Torres
Ada Torres
30 Oct 2026
Oceana Metals has more than doubled the known rare earth mineralisation footprint at its Serra Negra project in Brazil to over 4.5 square kilometres, while drilling has accelerated to four rigs. The company has also completed the acquisition of the project, but key assays, mining-right amendments and a maiden resource remain ahead.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Strickland Metals has ended the September quarter with a 9.25Moz AuEq resource at its Rogozna project, new geophysical targets in Serbia and A$75.7 million in cash and liquid investments. The next test is execution: drilling did not begin, licence approvals remain pending and a new managing director is yet to be appointed.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Raiz Invest delivered solid Q1 FY27 growth, with funds under management rising 20.2% to $2.40 billion and customer numbers reaching 354,202. But the fintech still cannot reliably quantify the potential impact of historical tax matters now under expert and regulatory review.
Claire Turing
Claire Turing
30 Oct 2026
Novatti’s AU/NZ quarterly transaction value rose to $1.2 billion, but regulatory disruption to international BPAY payments pushed revenue lower and left Cash EBITDA negative. The company is targeting an early 2027 relaunch while relying on pipeline conversion and product mix improvements to support its next phase of growth.
Claire Turing
Claire Turing
30 Oct 2026
Blue Energy is positioning its Queensland gas portfolio for potential demand from LNG exporters under proposed federal reservation rules, while seeking a farm-in partner for ATP 854. The company ended September with A$3.2 million in unaudited cash, no debt and a more cautious approach to Sapphire spending.
Victor Sage
Victor Sage
30 Oct 2026
Clinuvel has submitted NEURACTHEL Instant for regulatory review in three initial European Union markets, opening a potential pathway for its second pharmaceutical product. The decentralised review is expected to take 300 days, excluding clock stops, but the product is not yet approved anywhere.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive